Centrum BrokingPfizer (Buy)Target: ₹4,700CMP: ₹4,111.70Pfizer’s Q4-FY20 results were below our estimates primarily due to lower sales and EBITDA. Reve

from Business Line - Home https://ift.tt/3jaoiVO